CD8A and COVID-19: Furthermore, a pronounced expression of inhibitory markers such as PD-1, Tim-3, and CD39 on CD8+ T cells in severe patients demonstrates an exhausted CD8+ T-cell population that may lead to uncontrolled cytotoxicity response, reduced cellular immunity, and tissue damage with COVID-19 disease severity (69–71).